The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study) için istatistikler
Toplam ziyaret
| views | |
|---|---|
| The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study) | 2 |
Aylık toplam ziyaret
| views | |
|---|---|
| Eylül 2025 | 0 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 1 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 1 |
